MedPath

Comparison of the effect of PRP versus PRP plus gonadotropin and gonadotropin alone on ovarian rejuvenation in patients with diminished ovarian reserve

Phase 2
Conditions
Ovarian rejuvenation in diminished ovarian reserve patients.
Primary ovarian failure
E28.3
Registration Number
IRCT20151013024512N7
Lead Sponsor
Deputy of Research and Development, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
45
Inclusion Criteria

Female infertility
Diminish ovarian reserve (AMH<1.1 and AFC< 5-7)
20 to 48 years

Exclusion Criteria

Uterin anomaly
Polycystic Ovarian Syndrome
Male factor
Tubal factor

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Increase Anti-Müllerian hormone level. Timepoint: At the beginning of the study, every month up to 3 months. Method of measurement: Lab Test.
Secondary Outcome Measures
NameTimeMethod
Antral follicular count. Timepoint: 1 to 4 months later. Method of measurement: Transvaginal sonography.;Spontaneous pregnancy. Timepoint: 3 months later. Method of measurement: Lab test.;Entering assisted reproductive cycle. Timepoint: Once the AMH increases or the patient insists on doing assisted reproductive cycle. Method of measurement: Lab test.
© Copyright 2025. All Rights Reserved by MedPath